Mukka Proteins Ltd
Incorporated in 2003, Mukka Proteins
Ltd is a manufacturer and exporter
of Fish Meal and Fish oil[1]
- Market Cap ₹ 899 Cr.
- Current Price ₹ 30.0
- High / Low ₹ 56.6 / 28.5
- Stock P/E 19.4
- Book Value ₹ 14.7
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 11.1 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 32.6% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 52.2 to 72.5 days.
- Working capital days have increased from 163 days to 262 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | |
385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | |
Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 |
OPM % | 6% | 4% | 4% | 6% | 7% | 8% | 9% |
2 | 8 | 10 | 7 | 8 | 19 | 16 | |
Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 |
Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 |
Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 |
Tax % | 27% | 31% | 29% | 28% | 28% | 15% | 20% |
14 | 14 | 11 | 26 | 48 | 74 | 48 | |
EPS in Rs | 1.10 | 2.00 | 2.34 | 1.55 | |||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 9% |
TTM: | -27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 26% |
TTM: | -33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -14% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 20% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 |
Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 |
83 | 142 | 159 | 175 | 262 | 365 | 453 | |
74 | 95 | 129 | 119 | 166 | 179 | 183 | |
Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 |
49 | 78 | 79 | 83 | 85 | 85 | 94 | |
CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 |
Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 |
144 | 209 | 260 | 289 | 469 | 825 | 937 | |
Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
-20 | -25 | 2 | 5 | -56 | -150 | -112 | |
-23 | -28 | -14 | -11 | -3 | -51 | -35 | |
34 | 54 | 13 | 15 | 75 | 266 | 56 | |
Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 65 | -91 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 |
Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 |
Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 |
Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 |
Working Capital Days | 63 | 76 | 79 | 77 | 88 | 139 | 262 |
ROCE % | 15% | 9% | 18% | 24% | 19% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
30 Jun - Acquisition of FABBCO delayed from June to September 2025 due to procedural issues.
-
Closure of Trading Window
27 Jun - Trading window closed from July 1, 2025, till 48 hours post Q1 financial results announcement.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Annual Secretarial Compliance Report for FY 2024-25; minor delays noted, fines paid, overall compliance confirmed.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 May - Of newspaper publication of audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025.
-
Announcement Under Regulation 30 Of SEBI LODR Regulations.
15 May - Board approved corporate guarantees of Rs.16.03 Cr for subsidiary and related company credit facilities.
Business Overview:[1]
MPL manufactures Fish Protein products and supplies fish meal, fish oil and fish soluble paste
which is an essential ingredient in manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food). Further, fish oil also finds application in pharmaceutical products (Omega-3 pills and related products derived from fish oil), soap manufacturing, leather tanneries and paint industries